Pathstone Holdings, LLC Bristol Myers Squibb CO Transaction History
Pathstone Holdings, LLC
- $21.9 Billion
- Q2 2024
A detailed history of Pathstone Holdings, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Pathstone Holdings, LLC holds 184,888 shares of BMY stock, worth $9.71 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
184,888
Previous 212,969
13.19%
Holding current value
$9.71 Million
Previous $11.5 Million
33.52%
% of portfolio
0.04%
Previous 0.05%
Shares
3 transactions
Others Institutions Holding BMY
# of Institutions
2,435Shares Held
1.51BCall Options Held
29.7MPut Options Held
32.1M-
Vanguard Group Inc Valley Forge, PA187MShares$9.79 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.33 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.8 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$3.92 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.1 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $112B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...